Form 4: Amphastar Pharmaceuticals Executive Zhou Rong Reports Stock Disposals to Cover Tax Obligations

Senior EVP Zhou Rong of Amphastar Pharmaceuticals reports disposing of shares to cover tax liabilities related to vesting restricted stock units.

Summary

• On March 19, 2024, Zhou Rong, Senior EVP of Production Center at Amphastar Pharmaceuticals, filed a Form 4 with the SEC.
• The form details the disposal of common stock to cover tax liabilities associated with the vesting of restricted stock units (RSUs).
• Specifically, 1,219 shares were disposed of on March 15, 2024, 2,355 shares on March 16, 2024, and 1,961 shares on March 17, 2024, all at a price of $43.05 per share.
• Following these transactions, Zhou Rong directly owns 118,016 shares of Amphastar Pharmaceuticals common stock.
• Additionally, 99,668 shares are held indirectly through the Zhou Family Trust, where Zhou Rong serves as a trustee, and 5,000 shares are held by Zhou Rong's spouse.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the filing relates to routine stock disposals for tax purposes and doesn't indicate any fundamental change in the company's prospects.

Industry Context

Executive stock transactions are a common occurrence in publicly traded companies, often related to compensation and tax planning. These transactions are closely monitored by investors for insights into management's perspective on the company's value and future prospects.

Stakeholder Impact

• The stock disposal may have a minor impact on shareholders due to the increased supply of shares in the market, but the effect is likely to be minimal given the relatively small number of shares involved.

Key Dates